This post contains affiliate links, where we may receive a percentage of any sale made from the links on this page. Prices and availability are accurate at the time of publication. The 2025-26 NBA ...

Someone who bought a lottery ticket in Allegheny County is a whole lot richer. The Pennsylvania Lottery said a scratch-off worth $3 million was sold at a Shop 'n Save on Route 8 in Richland Township.

This post contains affiliate links, where we may receive a percentage of any sale made from the links on this page. Prices and availability are accurate at the time of publication. NBA Opening Night ...

A Seagoville resident claimed the second of four top prize-winning scratch-off tickets worth $3 million in the Texas Lottery's $3 Million Ca$h game. The Texas Lottery ...

The biggest stories of the day delivered to your inbox.

aTyr Pharma is a small-cap biotech focused on Efzofitimod for interstitial lung disease (ILD), a group of lung-scarring diseases. In 2021, the company completed a phase 1b/2a trial in pulmonary ...

Launching a new MMORPG against the long-established giants is a daunting prospect. World of Warcraft, FF14, Guild Wars 2, Runescape, Eve Online; the list goes on, making it a tough task to craft a ...

Ambitious MMORPG Ashes of Creation is gearing up for the next stage of its ongoing alpha test, and there's a lot to look forward to. In a new development livestream, Intrepid Studios reveals a big ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in SHASTA-3, SHASTA-4, and MUIR-3, the company’s global Phase 3 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of alternative endpoints in phase 3 oncology trials ...

A Wylie resident claimed a $3 million prize in a Texas Lottery scratch-off game last month. The Texas Lottery said the winning $3 Million Ca$h scratch-off ticket was ...

In its first global phase 3 readout, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody ivonescimab reduced the risk of progression or death by 48% in patients with ...